No Data
Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models
As of the end of April, TIGERMED (03347) has repurchased a total of 9.8063 million A-shares.
TIGERMED (03347) announced that as of April 30, 2025, the company's share repurchase dedicated securities Account...
TIGERMED (300347.SZ): A total of 1.1337% of shares have been repurchased, and the repurchase of shares has been completed.
Gelonghui, April 30th丨TIGERMED (300347.SZ) announced that as of April 30, 2025, the company's special securities account for share buyback has repurchased a total of 9,806,300 shares through centralized bidding, accounting for 1.1337% of the company's total share capital and 1.3219% of the total A-share capital. The highest Fill Price was 62.00 yuan/share, the lowest Fill Price was 48.17 yuan/share, and the total amount of transactions was 500,116,483.34 yuan (excluding transaction fees). The total amount of actual funds for this buyback has exceeded the buyback plan.
Hangzhou Tigermed Updates 2024 Final Dividend Details
TIGERMED (03347) will distribute a final dividend of 3 yuan for every 10 shares on July 31.
TIGERMED (03347) announced that it will distribute dividends on July 31, 2025, for the period ending December 3, 2024...
TIGERMED: NOTICE OF 2024 ANNUAL GENERAL MEETING
